Understanding the endocytosis and intracellular traffi cking of short interfering RNA (siRNA) delivery vehicle complexes remains a critical bottleneck in designing siRNA delivery vehicles for highly active RNA interference (RNAi)-based therapeutics. In this study, we show that dextran functionalization of silica nanoparticles enhanced uptake and intracellular delivery of siRNAs in cultured cells. Using pharmacological inhibitors for endocytotic pathways, we determined that our complexes are endocytosed via a previously unreported mechanism for siRNA delivery in which dextran initiates scavenger receptor-mediated endocytosis through a clathrin/ caveolin-independent process. Our fi ndings suggest that siRNA delivery effi ciency could be enhanced by incorporating dextran into existing delivery platforms to activate scavenger receptor activity across a variety of target cell types.
INTRODUCTION
New therapeutic approaches are continually needed for targeting diseaseassociated proteins. siRNA therapeutics are a potential approach capable of highly specific targeting of a wide range of proteins through the activation of RNA interference (RNAi) 3 . With the assistance of delivery vehicles, siRNAs are transported from the extracellular environment into the cytoplasms of eukaryotic cells. Aft er processing by the RNAi pathway proteins [4] [5] [6] [7] [8] , siRNAs guide degradation of target messenger RNAs (mRNAs) in a sequence-specifi c manner, resulting in a decrease in target protein levels. siRNA therapeutics are being developed for the treatment of cancers, genetic disorders, and infectious diseases 2 . While siRNA technology is well established in the laboratory environment, continued progress on the in vivo use of siRNAs will depend on the development of improved delivery vehicles.
Delivery vehicles are required to prevent degradation of siRNAs by serum nucleases, rapid fi ltration of siRNAs by the kidneys or siRNAinitiated immunogenic responses [9] [10] [11] . Moreover, if designed correctly, delivery vehicles can maximize delivery of the siRNAs to the target cells/ tissues of interest 12 . Currently, lipoplexes (complexes of siRNA with lipids) and polyplexes (complexes of siRNAs with polymers) are the most prevalent among ongoing clinical trials with some in vivo successes 3, 2, [13] [14] [15] [16] [17] . However, most existing delivery vehicles cannot be used clinically due to in vivo toxicity, immunogenicity or inactivity 16, [18] [19] [20] [21] . One means to address these limitations is through functional modifi cations [22] [23] [24] . One modifi cation, dextran, has demonstrated success in enhancing the activity of multiple delivery vehicles 14, [25] [26] [27] [28] . Functionally, dextran has been used to reduce toxicity, prevent opsonization and block non-specifi c binding [29] [30] [31] . Furthermore, functionalization with dextran polymers has been used for targeted delivery to various tissues [32] [33] [34] . While progress has been made on enhancing the systemic and extracellular traffi cking of delivery vehicles, transfection effi ciencies among delivery vehicles remain low relative to viral vectors, due in part to an incomplete understanding of siRNA-vehicle complex endocytosis and intracellular traffi cking 2, 35 . It remains unclear if RNAi is associated with a particular mechanism of endocytosis or if the mechanism of cytoplasmic delivery is specifi c to a certain cell type or delivery vehicle.
INVITED ARTICLE
Lipid-and polymer-based vehicles have been reported to use clathrinmediated endocytosis, caveolae-mediated endocytosis, macropinocytosis and phagocytosis [36] [37] [38] , though endocytosed material typically remains in endosomal compartments rather than entering the cytoplasm 35, 39 . siRNAs unable to escape early endosomes are exocytosed or degraded 40 . It has been postulated that siRNAs and complexes escape the endosomes via lipid fusion with the membrane, endosomal swelling (proton sponge eff ect), leaky membranes or, for vehicles with the appropriate functional groups, photochemical disruption 39 . However, these escape mechanisms are not used in all cases 41, 42 . Recent reports suggest that activation of RNAi may not even require endosomal escape 43 , as the RNAi machinery has been found to be associated with early endosomes. Developing a better understanding of the intracellular traffi cking events associated with RNAi remains a signifi cant hurdle toward improving the effi cacy of siRNA delivery vehicles.
Th e aim of this study was to investigate the impacts of chemical characteristics of delivery vehicles, specifi cally the inclusion of dextran, on infl uencing the endocytosis and intracellular traffi cking of siRNA-silica nanoparticle (SNP) complexes. SNPs were chosen as a delivery platform for their highly tunable synthesis, consistent physical conformation, low cytotoxicity and delivery effi cacy 17, 44, 45 . Our results showed that dextran signifi cantly enhanced the utility of SNPs for delivering siRNAs to cultured cells, by initiating their uptake through a scavenger receptormediated endocytosis mechanism that is clathrin/caveolae-independent. Subsequent degradation of the SNPs, attributed in part to the acidic conditions of intracellular vesicles, suggested a means for activating release of the siRNAs from the SNPs and initiation of the silencing cascade.
METHODS

Materials
See Supplementary Table 1 for a detailed list of reagents.
Cell culture H1299 cells constitutively expressing a 2 hour half-life EGFP were generously provided by Dr. J. Kjems (University of Aarhus, Denmark). H1299 and HeLa cells were maintained in DMEM High Glucose, 10% fetal bovine serum, and 1% penicillin/streptomycin. 1% Geneticin was included in the H1299 culture medium to maintain EGFP expression. Cells were incubated at 37°C in 5% CO 2 , at 100% relative humidity, and subcultured every 4-5 days by trypsinization.
Synthesis of silica nanoparticles
A 500 mL round bottom Schlenk fl ask was charged with 150 mL of absolute ethanol and 50 mL of Milli-Q water 18 MΩ with constant stirring. Dextran (9-11 kDa, 2.4 × 10 −6 mol, 24 mg) was dissolved in 10 mL of Milli-Q water and added, followed by 10 mL of NH 4 OH (~30% as NH 3 ). Tetraethyl orthosilicate (TEOS) (2.4 mmol, 0.53 mL) was added dropwise via syringe. Th e mixture was stirred for 10 minutes at room temperature (RT) under nitrogen followed by addition of (3-Aminopropyl) triethoxysilane (APTES) (concentration varied as mole percentage of TEOS; e.g., 40% APTES used 0.96 mmol, 0.224 mL). Th e reaction mixture was stirred for 24 hours at RT under nitrogen atmosphere and purifi ed by pressure fi ltration using an Ultracel regenerated cellulose membrane (30 kDa MWCO) at 40 psi and rinsed three times with Milli-Q water. Th e fi ltered solids were suspended in Milli-Q water and sonicated until well dispersed.
Zeta potential
A Malvern Zetasizer Nano ZS was used to determine the zeta potential (mV) of SNPs. Measurements were collected using 1 mg/mL of SNP in HEPES buff er.
EGFP silencing analysis
H1299-EGFP cells were seeded in 96-well plates at a density of 200,000 cells/mL in 100 uL of growth media without antibiotics. Cells were treated 24 hours post-seeding with a 50 μL transfection solution containing Opti-MEM, siRNA and delivery vehicle that was mixed for 30 minutes prior to addition to the cells. Final concentrations were maintained at 100 nM siRNA in either 2.3 μg/mL Lipofectamine 2000 (LF2K) or 200 μg/mL SNP. Cells were incubated in the transfection solutions at 37°C, 5% CO 2 and 100% humidity. At 24 hours aft er transfection, cells were washed twice with Dulbecco's NaCl/Pi (DPBS), and EGFP fl uorescence was quantifi ed with a Gemini EM fl uorescent plate reader (Molecular Devices) at 480 nm excitation and 525 nm emission. Fluorescence intensity was normalized to control wells treated with a delivery vehicle but no siRNA. Cytotoxicity was monitored by microscopy of cell morphology and EGFP expression and was not observed in any of the treatments (Supplementary Fig. 1 ). HeLa cells were seeded in 96-well plates at a density of 100,000 cells/mL in 100 μL of antibiotic-free growth media. Cells were treated 24 hours post-seeding with a 50 μL transfection solution containing Opti-MEM, 20 ng pd2EGFP-N1 and 2.3 μg/mL LF2K. Cells were then treated with a 50 μL transfection solution containing Opti-MEM, siRNA and delivery vehicle that was mixed for 30 minutes prior to addition to the cells. Final concentrations were maintained at 100 nM siRNA in either 2.3 μg/mL LF2K or 200 μg/mL SNP. Cells were incubated in the transfection solutions at 37°C, 5% CO 2 and 100% humidity. Cells were washed 4 hours post-transfection with antibiotic free growth media. At 24 hours aft er transfection, cells were washed twice with DPBS, and EGFP fl uorescence was quantifi ed with a Gemini EM fl uorescent plate at 480 nm excitation and 525 nm emission. Fluorescence intensity was normalized to control wells treated with a delivery vehicle but no siRNA (Supplementary Fig. 2 ). Cytotoxicity was monitored by microscopy of cell morphology and EGFP expression and was not observed in any of the treatments.
Inhibition experiments
EGFP-expressing H1299 cells were seeded in 12-well plates at a density of 150,000 cells/well and cultured in antibiotic free growth media. Immediately prior to transfection, cells were washed with media and replaced with inhibitor containing media for the appropriate pre-treatment time: chlorpromazine (10 μg/mL, 30 minutes), fi lipin complex III (2 ug/mL, 60 minutes), cytochalasin D (5 μg/mL, 15 minutes), temperature (4°C, 60 minutes) and 500 kDa dextran sulfate (200 μg/mL, 30 minutes). Following pre-treatment, cells were treated with 100 μL of various transfection solutions in Opti-MEM (200 nM siRNA and either 2.3 μg/mL LF2K or 200 μg/mL SNP) and incubated at 37°C, 5% CO 2 and 100% relative humidity. Cells were washed 4 hours post-transfection with media containing 20 μg/mL heparin for 15 minutes at 37°C to remove extracellularly bound complexes. Antibiotic-free media was then added to the cells.
For FACS analysis, cells were trypsinized 24 hours post-transfection, pelleted by centrifugation (200 g) at 4°C and re-suspended in DPBS. Th e cells were then transferred into 5 mL round bottom tubes. Immediately prior to analysis, cells were treated with DAPI at a fi nal concentration of 1 μg/mL for live/dead analysis. Cells were analyzed using a Becton Dickinson Influx Flow Cytometer to detect DAPI (355/460), EGFP (488/530) and Dy547-tagged siRNA (561/585), gated to include 10,000 events/sample. For comparison across experiments, the instrument was calibrated using Sphero Rainbow Calibration particles. Geometric mean was used to calculate fl uorescence intensity values among samples. EGFP fl uorescence was normalized to particle only controls treated with the corresponding inhibitor. Dy547 fl uorescence was normalized to the uptake of siRNA only (no vehicle) controls.
HeLa cells were seeded in 96-well plates in antibiotic-free growth media. Cells were transiently transfected 24 hours post-seeding with pd2EGFP-N1 and LF2K. Immediately prior to transfection, cells were washed with media and replaced with inhibitor containing media for the appropriate pre-treatment time and incubated at 37°C, 5% CO 2 and 100% humidity. Cells were washed 4 hours post-transfection with antibiotic free growth media. Cells were washed twice with DPBS
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24 hours post-transfection, and EGFP fluorescence was quantified using a Gemini EM fl uorescent plate reader at 480 nm excitation and 525 nm emission. Fluorescence intensity was normalized to control wells treated with a delivery vehicle but no siRNA (Supplementary Fig. 2 ). Cytotoxicity was monitored by microscopy of cell morphology and EGFP expression and was not observed in any of the treatments.
Transmission electron microscopy/energy dispersive X-ray spectroscopy Intracellular transmission electron microscopy (TEM): EGFP-expressing H1299 cells were seeded in six-well plates at a density of 400,000 cells/ well and cultured in antibiotic-free media. Cells were treated 24 hours post-seeding with 200 μL transfection solutions (Opti-MEM, 200 nM siRNA and 200 μg/mL SNP) and incubated at 37°C, 5% CO 2 and 100% relative humidity. Cells were trypsinized 24 hours post-transfection and pelleted by centrifugation (200 RCF) at 4°C. Samples were fi xed using 2.5% formaldehyde/glutaraldehyde in DPBS, stained with 1% osmium tetroxide in DPBS, dehydrated through a graded series of ethanol concentrations and embedded in Spurr resin. Samples were sectioned to a thickness of ~90 nm using an RMC MYX ultramicrotome and placed onto a 200-mesh formvar coated copper grid. Samples were additionally stained with uranyl acetate and lead citrate. Images were acquired using a JEOL 100CXII transmission electron microscope operating at an accelerating voltage of 100 keV and equipped with an Olympus MegaView III digital camera. Energy dispersive X-ray spectroscopy (EDS) analysis was performed on JEOL 2200FS transmission electron microscope operating at an accelerating voltage of 200 keV.
Confocal microscopy
EGFP-expressing H1299 cells were seeded in 4-well plates at a density of 75,000 cells/well and cultured in antibiotic free growth media. Immediately prior to transfection, cells were washed with media and replaced with inhibitor-containing media for the appropriate pre-treatment time: chlorpromazine (10 μg/mL, 30 minutes), filipin complex III (2 μg/mL, 60 minutes), cytochalasin D (5 μg/mL, 15 minutes) and 500 kDa dextran sulfate (200 μg/mL, 30 minutes). Following pre-treatment, cells were treated with 100 μL of various transfection solutions in Opti-MEM (200 nM siRNA and either 2.3 μg/mL LF2K or 200 μg/mL SNP) and incubated at 37°C, 5% CO 2 and 100% relative humidity. Cells were washed 4 hours post-transfection with Opti-MEM to remove extracellularly bound complexes and imaged 4 hours and 24 hours post-transfection ( Supplementary  Fig. 3,4) .
Confocal images were taken using an Olympus FluoView 1000 spectral-based laser scanning confocal microscope. An Olympus PLAPON 60×/1.42 oil objective was used to acquire all images. EGFP (488/530) fl uorescence was measured using an excitation of 488 nm with a multi-line Argon laser, and displayed as green (LUT). Dy547 (559/568) fl uorescence (siRNA) was excited at 559 nm by a HeNe laser, and displayed as red (LUT). Th e focal plane for each image was chosen based on the highest intensity EGFP fluorescence. All images were collected sequentially as single XY images and used two-count Line Kalman averaging.
Acidic degradation
SNPs were dispersed in acetic acid (pH 4.75) at a concentration of 0.5 mg/ml and incubated at RT. Aft er 16 hours, the samples were centrifuged and washed three times with DPBS. Samples were prepared for imaging by placing 5 μL of the sample onto a 200-mesh formvar coated copper grid and air dried overnight. Images were acquired using a JEOL 100CXII transmission electron microscope operating at an accelerating voltage of 100 keV and equipped with an Olympus MegaView III digital camera.
Polyacrylamide binding gels
Solutions were prepared in DPBS, using 200 nM siRNA, and 200 μg/mL SNP, and allowed to incubate for 30 minutes. Milli-Q water (pH 7.00, control) or acetic acid (pH 4.75) was added to the sample and incubated at RT. After 16 hours, the samples were centrifuged to pellet the SNPs, washed with Milli-Q water and suspended in DPBS. Each sample was mixed with 300 μg/mL heparin (Sigma) for 3 minutes to elute the siRNA from the SNPs and then resolved on a 12% polyacrylamide gel. In lieu of centrifugation and washing, siRNA samples without SNP were diluted with Milli-Q water. Nucleic acid detection was performed with SYBR gold staining, imaging was performed with the Molecular Imager ChemiDoc XRS System, and analysis was performed using ImageJ 46 .
Statistical analyses
Multiple comparisons were performed with two-way ANOVA followed by Tukey's HSD post hoc analysis (Supplementary Tables 2-4 ). Analyses were performed using OriginPro 8 and Microsoft Excel.
RESULTS
Effect of amine and dextran content on siRNA silencing effi ciency SNPs were synthesized with varying concentrations of the primary amine-containing moiety APTES, with and without dextran, to determine if these variables (amine content and the presence of dextran) infl uenced the delivery or silencing of the siRNA cargo ( Fig. 1) . At 24 hours post-transfection, seven of the nine dextran-containing SNPs achieved signifi cant silencing compared to the nanoparticle only controls. Six achieved >50% reduction in EGFP levels and were statistically equivalent to LF2K. Increasing amines resulted in increased silencing, with maximal silencing achieved at 40% APTES, with little gain and perhaps some loss of activity at higher amine contents. Only one non-dextran SNP achieved statistically signifi cant reduction in EGFP levels, again at 40% APTES. SNPs were characterized for their potential to bind siRNA using zeta potential (Supplementary Fig. 5 ). Both the silencing data (~40% APTES) and ζ potential (~27 mV) results suggest that there may be an ideal amine content/charge density for siRNA delivery vehicles, though further characterization would be required to establish this concretely. As our objective was to understand better the uptake and traffi cking mechanism for SNPs that yield active silencing, we focused our subsequent analyses on our best performing SNP (40% APTES with dextran).
Inhibition of siRNA endocytosis and silencing
Having confi rmed the ability of our SNPs to deliver siRNAs that then silence the EGFP target, we wished to evaluate the mechanism of uptake for our SNP-siRNA complexes as compared to LF2K lipoplexes and naked siRNAs. From the literature, we selected a number of chemical inhibitors for individual endocytosis pathways ( Table 1 ) and investigated the quantity of siRNA delivered (Fig. 2) and the silencing achieved (Fig. 3) following delivery of siRNAs using our most eff ective SNP (40% APTES + Dextran), LF2K or no vehicle.
As expected, intracellular levels of siRNA were signifi cantly increased using LF2K (5× increase) and SNPs (40× increase), compared to naked siRNA (Fig. 2, see insets) . Delivery by LF2K was signifi cantly reduced by the combination of chlorpromazine and fi lipin, low temperature (4°C) and dextran sulfate. For SNP delivery, the active inhibitors were chlorpromazine, cytochalasin D, low temperature (4°C) and dextran sulfate. Th e diff erential eff ects of the inhibitors indicate that the SNPs were endocytosed through a mechanism distinct from that of LF2K. Moreover, plasmid DNA delivered with our SNPs (Supplementary Fig. 6 ) did not result in significant overexpression whereas plasmid delivery with LF2K resulted in significant gene overexpression, further suggesting that SNPs and LF2K deliver through diff erent pathways. However, the strong impact of dextran sulfate suggests that both SNP and LF2K complexes used scavenger receptor-mediated uptake in delivering siRNAs. Our FACS analyses were corroborated using confocal microscopy at 4 hours and 24 hours aft er transfection (Supplementary Fig. 3,4) . Likewise, to examine the generality of our results across cell types, replicate experiments were performed in HeLa cells, producing similar results (Supplementary Fig. 2) .
In examining the resulting silencing in the presence of inhibitors (Fig. 3) , low temperature and dextran sulfate signifi cantly reduced silencing following delivery by both LF2K and our SNP. Th is is a direct refl ection of the inhibition observed for siRNA delivery (Fig. 2) . This suggests that both SNP-siRNA complexes and LF2K-siRNA lipoplexes are eff ectively endocytosed and processed by the scavenger receptor pathway. However, there are discrepancies between the inhibition of delivery and the reduction in silencing activity. Cytochalasin D also signifi cantly inhibited silencing by SNP delivery, indicating that the processing of endocytotic vesicles on actin networks may be essential for silencing, regardless of the pathway of endocytosis.
Intracellular traffi cking of SNPs
Using TEM, we confi rmed the uptake of our SNPsiRNA complexes and identified the subcellular locations to which SNPs were traffi cked (Fig. 4) . In all cases, we confi rmed the presence of our SNPs using EDS line scans to detect silicon, which should not be present at signifi cant levels endogenously (Fig. 4c-f) . The images showed SNPs localized within membrane-bound endocytotic vesicles. Visual inspection of the signal intensity for the endocytosed particles suggested that the density of the interiors of the particles was decreased relative to particles before endocytosis. Th is observation was further supported by the appearance of degraded SNPs adjacent to the cell membrane, suggesting that these have been recently exocytosed from the cells.
Acidic degradation of SNPs
To determine if the observed intracellular degradation of our SNPs could be attributed to the acidic environments of some vesicles, we tested whether acidic pH would result in similar degradation patterns in vitro (Fig. 5) . Both visual inspection (compare signal intensities for Fig. 5a,b) and quantifi cation of the signals from multiple treated and untreated particles (Fig. 5c) indicate that acidic conditions promote SNP degradation with maximum degradation, roughly 40% of the TEM signal, in the centers of the particles. Th e particles appear rough aft er exposure to acid, again refl ecting what was observed in the cellular experiments, suggesting some surface degradation. However, the Figure 5 SNP degradation under acidic conditions. Relative intensity (I) of SNPs (40% APTES + Dextran) exposed to neutral or acidic conditions. SNPs were suspended in a (a) pH 7.00 or (b) pH 4.75 solution for 16 hours at RT and imaged using TEM. (c) Percent degradation was determined by comparing the difference in relative intensity at pH 4.75 to that at pH 7.00, using a normalized particle diameter. Average diameter of pre-acid particles was 381 nm ± 32 nm; after acid, the average diameter was 375 nm ± 28 nm. Error bars represent ±1 standard deviation; n = 10. Scale bars are 200 nm. Results are normalized to siRNA exposed to pH 7.00. Error bars represent ±1 standard deviation; n = 3. Statistical analysis was performed using one-way ANOVA, followed by Tukey's HSD post-hoc analysis. A signifi cant difference (p < 0.05) between acidic and neutral conditions was found for siRNA binding (a,b) but not degradation (c,d) . average diameter of the particles did not change signifi cantly during the in vitro acid exposure.
siRNA binding under acidic conditions
We hypothesized that the degradation of the SNPs would contribute to the release of siRNAs from the complexes, resulting in a more rapid activation of silencing than would be achieved by purely diff usive release. To examine whether acidic conditions promoted nucleic acid release from SNPs, we incubated complexes of SNPs with siRNAs under neutral and acidic conditions. The amount of nucleic acid retained on the particles aft er exposure to acid was assayed using gel electrophoresis. Acidic conditions resulted in only 4% of the original nucleic acid being retained in complexes with the SNPs (Fig. 6a,b) .
The relatively minimal degradation of the naked nucleic acids in acid suggested that the reduction in retained material was not due to degradation of the nucleic acids but a reduced ability of the particles to bind them (Fig. 6c,d ).
DISCUSSION
Designing eff ective, non-toxic siRNA delivery vehicles remains a critical challenge in the development of siRNA therapeutics. Here, we used SNPs as a means of identifying chemical characteristics of delivery vehicles that correlate with high activity of the delivered siRNA cargo. Th e SNP system is convenient as it allows for changes in the chemical functionality of the vehicle without altering its physical conformation. We plan to use the SNP system as a platform for further evaluation of other chemical functionalities (e.g., biodegradable disulfi de linkages, PEGylation) that may enable high activity of the delivered siRNAs, with the goal of identifying characteristics that apply to any siRNA delivery vehicle. Moreover, by modifying the synthesis protocol, we will also be able to examine these characteristics on particles of multiple sizes. Our approach diff ers from purely combinatorial eff orts that have been undertaken 48 , where both the chemical functionality and the molecular structure/size of the vehicle can change simultaneously, potentially confounding why some vehicles result in higher siRNA activity than others.
Our data suggest that the majority of silencing that occurs results from uptake of either LF2K lipoplexes or SNP-siRNA complexes through a clathrin/caveolae-independent, energy-dependent process mediated by scavenger receptors. While nucleic acids and gold nanoparticles have been shown to be taken up via scavenger receptor-mediated endocytosis 49, 50 , this uptake mechanism was limited to macrophages and was either clathrin-or caveolae-dependent. Utilization of a clathrin/caveolae-independent, scavenger receptor-mediated pathway in non-macrophage cells distinguishes this mechanism of uptake from those previously reported.
For both vehicles, there were cases where changes in siRNA uptake and silencing were not correlated. For LF2K, where uptake inhibition by chlorpromazine and fi lipin did not result in a reduction in silencing, this may be because the amount of reduction in siRNA levels was small despite it being statistically signifi cant. Additionally, it has been shown that lipoplexes enter cells through multiple pathways 51, 52 , making the inhibition of any one or two pathways, especially if those are not primary pathways to silencing, less likely to aff ect silencing.
For SNPs, the results are more complex. Inhibition by chlorpromazine, either in the presence or absence of fi lipin, resulted in a signifi cant reduction in uptake with no concomitant reduction in silencing. Th is suggests inhibition of a non-productive uptake pathway. In contrast, cytochalasin D resulted in comparable levels of inhibition of siRNA uptake and a signifi cant reduction in silencing. Th is indicates that SNP-siRNA complexes associate with the actin network, either directly or while in vesicles, and that this association is essential for delivering siRNAs in a manner (e.g., to a specifi c subcellular location) that eventually results in silencing. It is also worth noting that uptake, traffi cking, and silencing are dynamic processes, and measurements at a single time point do not necessarily refl ect a steady-state.
It is important to note that our SNPs deliver considerably more siRNA to cells than LF2K (~eight-fold, Fig. 2) . Th is indicates that our SNPs deliver more siRNA than many delivery vehicles (using LF2K delivery as a reference) [53] [54] [55] . However, the degree of silencing achieved by the delivered siRNAs was only comparable to LF2K. Th is may indicate that a large fraction of the siRNAs delivered by SNPs is inactive due to sequestration, either by being retained on the SNPs or by being trapped in vesicles.
51 Th ese internalized siRNAs may then be degraded prior to achieving silencing, mitigating any improvement in function that would result from delivery of higher quantities of siRNA. If this is the case, our SNPs may be valuable for delivering chemically modifi ed siRNAs, in particular those designed for resistance to nucleases or enhanced endosomal escape, potentially providing a facile approach for increasing or extending the persistence of maximal silencing. 56 Among the various classes of scavenger receptors, dextran sulfate is a known inhibitor of acetyl-LDL scavenger receptors, which are found among class A (SCARA1/SR-AI/II, SCARA2/MARCO) and class H (FEEL 1/stabilin-1/CLEVER-1, FEEL-2/stabilin-2/HARE) 57, 58 . These receptors recognize targets with a high density of negative charges, common among bacterial polysaccharides 57 . While previously considered to be macrophage specifi c, scavenger receptors have been identified across multiple cell types including endothelial, smooth muscle, dendritic, fi broblast and epithelial cells. 58 Scavenger receptors are known to induce phagocytosis and macropinocytosis, although the exact signaling mechanism remains unknown. 59 Scavenger receptors can enact a variety of functional responses due to their association with various co-receptors (SRC family kinases, Toll-like receptors, β-integrins and tetraspanins) 59 . Our results suggest that the scavenger receptors used by our SNPs may associate with dynamin-independent GTPases of the Rho family, given their association with other scavenger receptors that had a reported role in actin polymerization and clathrin/caveolaeindependent endocytosis. 60 While the traffi cking of high amine-content particles such as our SNPs within acidic endosomes suggests that siRNA release into the cytoplasm is due to the proton sponge eff ect 61 , our results do not support this mechanism for endosomal release. From our TEM images, SNPs were only observed within membrane-bound vesicles and never observed in the nucleus or cytoplasm. Th ese observations, in concert with the inability of SNPs to deliver plasmid DNA, are inconsistent with release mechanisms that require the endosomal membrane to rupture. Rather, it seems that only the siRNAs escape the endosomes in our system and that escape occurs aft er the SNP-siRNA complex has dissociated. Th is is further substantiated by our fi ndings that acidic conditions inhibit the binding of siRNAs to SNPs. Formation of endosomal membrane pores would enable siRNA release into the cytoplasm. However, our SNPs lack any specifi c functionality designed to generate pores 62 , making this unlikely. It may also be that siRNAs do not need to escape the endosomes to activate RNAi. Recent evidence has shown that RNAi pathway proteins, specifically Dicer and Ago2, are associated with vesicle and ER membranes 43, 63 . It is possible that siRNAs are recognized in the endosomes aft er release from the SNPs, with the RNAi proteins able to shuttle them across the endosomal membrane. Based on our current results, however, the exact mechanism by which siRNAs achieve endosomal escape and initiate silencing remains unclear.
Th e design of siRNA delivery vehicles remains a somewhat haphazard process, without clear rules for which chemical and physical features provide the greatest probability of high siRNA activity. In this work, we have demonstrated that dextran associates with scavenger receptors to initiate clathrin/caveolae-independent endocytosis, and that internalization by this pathway results in active siRNA delivery. In doing so, we have identified both a vehicle design variable (presence of dextran) © World Scientific Publishing Co./Imperial College Press
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and a biological mechanism (clathrin/caveolae-independent, scavenger receptor-mediated endocytosis) that warrant further examination for their contributions to the high activity of delivered siRNAs. Going forward, we hope to examine the generality of these rules for siRNA delivery vehicles based on lipids, polymers and nanoparticles. Supplementary 
